These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36610518)

  • 1. CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells.
    Kotidis P; Donini R; Arnsdorf J; Hansen AH; Voldborg BGR; Chiang AWT; Haslam SM; Betenbaugh M; Jimenez Del Val I; Lewis NE; Krambeck F; Kontoravdi C
    Metab Eng; 2023 Mar; 76():87-96. PubMed ID: 36610518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoengineering Chinese hamster ovary cells: a short history.
    Donini R; Haslam SM; Kontoravdi C
    Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans.
    Nguyen NTB; Lin J; Tay SJ; Mariati ; Yeo J; Nguyen-Khuong T; Yang Y
    Sci Rep; 2021 Jun; 11(1):12969. PubMed ID: 34155258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
    Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
    Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered CHO cells for production of diverse, homogeneous glycoproteins.
    Yang Z; Wang S; Halim A; Schulz MA; Frodin M; Rahman SH; Vester-Christensen MB; Behrens C; Kristensen C; Vakhrushev SY; Bennett EP; Wandall HH; Clausen H
    Nat Biotechnol; 2015 Aug; 33(8):842-4. PubMed ID: 26192319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based analysis of N-glycosylation in Chinese hamster ovary cells.
    Krambeck FJ; Bennun SV; Andersen MR; Betenbaugh MJ
    PLoS One; 2017; 12(5):e0175376. PubMed ID: 28486471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity.
    North SJ; Huang HH; Sundaram S; Jang-Lee J; Etienne AT; Trollope A; Chalabi S; Dell A; Stanley P; Haslam SM
    J Biol Chem; 2010 Feb; 285(8):5759-75. PubMed ID: 19951948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic engineering challenges of extending N-glycan pathways in Chinese hamster ovary cells.
    Wang Q; Wang T; Yang S; Sha S; Wu WW; Chen Y; Paul JT; Shen RF; Cipollo JF; Betenbaugh MJ
    Metab Eng; 2020 Sep; 61():301-314. PubMed ID: 32663509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells.
    Deng Z; Yi X; Chu J; Zhuang Y
    J Biotechnol; 2019 Dec; 306():159-168. PubMed ID: 31604106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.
    Spahn PN; Hansen AH; Hansen HG; Arnsdorf J; Kildegaard HF; Lewis NE
    Metab Eng; 2016 Jan; 33():52-66. PubMed ID: 26537759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of GlcNAc-rich
    Szulc B; Sosicka P; Maszczak-Seneczko D; Skurska E; Shauchuk A; Olczak T; Freeze HH; Olczak M
    J Biol Chem; 2020 Nov; 295(48):16445-16463. PubMed ID: 32938718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for Glycoprotein Production.
    Clarke EC
    Methods Mol Biol; 2024; 2762():329-351. PubMed ID: 38315375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of protein/glycan interaction on site-specific glycan heterogeneity.
    Losfeld ME; Scibona E; Lin CW; Villiger TK; Gauss R; Morbidelli M; Aebi M
    FASEB J; 2017 Oct; 31(10):4623-4635. PubMed ID: 28679530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-resistant CHO glycosylation mutants.
    Patnaik SK; Stanley P
    Methods Enzymol; 2006; 416():159-82. PubMed ID: 17113866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A; Shanmugam D; Gadgil M
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.